<DOC>
	<DOCNO>NCT01483963</DOCNO>
	<brief_summary>The objective study assess safety , effectiveness , immunogenicity AA4500 treatment adhesive capsulitis .</brief_summary>
	<brief_title>AA4500 Treatment Adhesive Capsulitis Shoulder</brief_title>
	<detailed_description>This study Phase 2a , open-label , dose-ranging study safety effectiveness AA4500 treatment adhesive capsulitis shoulder . To eligible treatment , subject must unilateral idiopathic adhesive capsulitis shoulder restrict range motion affect shoulder least 3 month 12 month . Subjects screen study eligibility within 30 day injection study drug . Approximately 50 adult woman men enrol study . Following screen determination study eligibility , Assignment Cohorts 1-4 sequential . Subjects assign Cohorts 1 4 may receive 3 injection AA4500 accord cohort assignment . Each injection separate minimum 21 day . Subjects assign Cohort 5 receive home shoulder exercise , subject assign Cohorts 1-4 receive AA4500 home shoulder exercise . Subjects Cohort 5 offer physical therapy session period 2 month follow completion study . Dosing range 0.29 mg 0.58 mg vary volume .</detailed_description>
	<mesh_term>Periarthritis</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Bursitis</mesh_term>
	<criteria>1 . Be male female great equal 18 year age 2 . If female childbearing potential , negative urine pregnancy test use effective contraception method ( ie , abstinence , intrauterine device ( IUD ) , hormonal ( estrogen/progestin ) contraceptives , barrier control ) least one menstrual cycle prior study enrollment one menstrual cycle follow end study , surgically sterile 3 . Have unilateral idiopathic adhesive capsulitis one shoulder least 3 month 12 month screen visit Stage 2 ( frozen adhesive stage ) , determine investigator 4 . Have normal range motion contralateral shoulder , determine investigator 5 . Have restrict active range motion ( AROM ) affect shoulder define : deficit least 60 degree total AROM affect shoulder compare total AROM contralateral shoulder deficit least 30 degree AROM least one follow plane compare contralateral shoulder : Forward flexion Abduction External rotation elbow 90 degree abduction Internal rotation elbow 90 degree abduction 6 . Voluntarily sign date inform consent agreement approve Institutional Review Board/Independent Ethics Committee ( IRB/IEC ) . The subject must also sign authorization form allow disclosure protect health information ( PHI ) . The PHI authorization form inform consent form may integrate form may separate form depend institution . 7 . Be able complete understand various rating instrument English . 1 . Is pregnant lactate female female intend become pregnant study 2 . Is male intend father child study 3 . Has receive treatment adhesive capsulitis plan receive treatment adhesive capsulitis time study include limited : physical therapy acupuncture within 2 week first injection AA4500 intraarticular intrabursal injection ( ) lidocaine ; suprascapular nerve block ; corticosteroid ; electroanalgesic and/or thermoanalgesic modality within 1 month screen visit intraarticular intrabursal injection ( ) sodium hyaluronate within 3 month screen visit glenohumeral distension arthrography and/or surgical intervention ( include shoulder manipulation anesthesia ) time 4 . Has follow condition , determine investigator : Adhesive capsulitis result traumatic injury Pain affect shoulder rest great equal 4 11point pain scale Active subacromial impingement affect shoulder Calcified tendonitis affect shoulder Glenohumeral joint arthritis affect shoulder Arthrosis affect shoulder Chondrolysis affect shoulder Subscapularis tendon rupture affect shoulder Other rotator cuff injury affect shoulder Uncontrolled hypertension Uncontrolled diabetes Uncontrolled thyroid disease History thrombosis postthrombosis syndrome Physical impairment would preclude perform protocol define exercise Active infection area treat Clinically significant neurological disease Coagulation disorder , use anticoagulant ( except less equal 150 mg aspirin ) within 7 day prior injection day Known active hepatitis B C ( history hepatitis A permit ) Other significant medical condition ( eg , morbid obesity , cervical disc disease ) , investigator 's opinion would make subject unsuitable enrollment study 5 . Is unwilling unable cooperate requirement study include completion schedule study visit . 6 . Has receive oral intravenous steroid reason within 3 week screen visit 7 . Has receive investigational drug treatment within 30 day first dose study drug . 8 . Has know systemic allergy collagenase excipient AA4500 procedural medication . 9 . Has , time , receive collagenase treatment adhesive capsulitis . 10 . Is unable undergo xray MRI ( contraindication ) evaluation affect shoulder . 11 . Is plan treat commercial Xiaflex time study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>